Polycystic kidney disease (PKD) is a genetic or acquired disorder char
acterized by progressive distention of multiple tubular segments and m
anifested by fluid accumulation, growth of non-neoplastic epithelial c
ells and remodeling of the extracellular matrix resulting ultimately i
n some degree of renal functional impairment, with the potential for r
egression following removal of the inductive agent(s). It is due to an
aberration of one or more factors regulating tubular morphogenesis. H
uman PKD can pursue a rapid course with renal failure occurring perina
tally (infantile PKD) or an indolent course without renal failure deve
loping during the life of the individual (adult PKD). Human acquired P
KD develops in atrophic and scarred end-stage kidneys with non-cystic
forms of renal disease. Cell proliferation, fluid secretion, impaired
cell-cell and cell-matrix interaction, defective function of the Golgi
apparatus, cell undifferentiation, and an abnormal matrix have been i
mplicated in the pathogenesis of PKD based on clinical and experimenta
l studies. Under normal conditions, the dynamic turnover of tubular ep
ithelia and matrices are tightly regulated to maintain tubular morphol
ogy. The basic defect in PKD is tubular dysmorphogenesis. Our finding
indicates that the principal phenotypic features of autosomal dominant
PKD (ADPKD) are altered structure and function of the Golgi complex,
altered structure and composition of the matrix and cell undifferentia
tion, all of which are probably interrelated. If the gene product of t
he ADPKD 1 gene results in a defective matrix, the abnormal Golgi func
tion and cell differentiation may be due to faulty matrix-cell communi
cation.